XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Financial Statements - Narrative (Details)
$ in Thousands
6 Months Ended 15 Months Ended
Dec. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
loan
Jun. 30, 2021
USD ($)
loan
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Unusual or Infrequent Item, or Both [Line Items]              
Allowance for credit loss $ 37,607 $ 39,493 $ 39,493 $ 43,197 $ 38,520 $ 36,800 $ 28,707
Unfounded credit commitment 808 1,808 1,808 1,702      
Financing receivable 3,823,238 3,817,273 3,817,273        
Net loans held-for-investment 3,785,631 $ 3,777,780 3,777,780        
Cumulative Effect, Period of Adoption, Adjustment              
Unusual or Infrequent Item, or Both [Line Items]              
Increase in allowance for credit losses 11,100            
Allowance for credit loss 10,353            
Unfounded credit commitment 737     $ 0      
PCD loan related reserves 6,800            
Non-PCD loan related reserves $ 4,300            
COVID-19              
Unusual or Infrequent Item, or Both [Line Items]              
Loan modification program, payment deferral period   90 days          
Loan modification program, extension for payment deferral period   90 days          
Net loans held-for-investment   $ 21,500 21,500        
COVID-19              
Unusual or Infrequent Item, or Both [Line Items]              
Financing receivable   $ 232,200 $ 232,200        
Number of loans approved | loan   2,300 2,300        
Net loans held-for-investment   $ 132,700 $ 132,700        
Loan processing fee   9,500 9,500        
Loan processing fee recognized as earnings   $ 2,800 $ 4,700        
Number of loans outstanding | loan   1,453 1,453